Insights

Gathering insights about Adaptive…

Similar companies to Adaptive

Adaptive Tech Stack

Adaptive uses 8 technology products and services including Varnish, Cloudflare, MySQL, and more. Explore Adaptive's tech stack below.

Varnish
Caching
Cloudflare
Content Management System
MySQL
Database
jQuery
Javascript Libraries
Node.js
Programming Languages
Lua
Programming Languages
HSTS
Security
Nginx
Web Servers

Media & News

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation sequencing (NGS)-based clonoSEQ® test for measurable residual disease (MRD) assessment will be included in 89 abstracts, including 36 oral presentations, at the 67th Annual Meeting of the American Society of Hematology (ASH) taking place Dec. 6–9, 2025, in Orlando. Key highlights include: Abstracts featuring clonoSEQ MRD data span multiple myeloma (MM), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), and other blood cancers, underscoring its position as the most widely used and validated next-generation sequencing-based MRD test in lymphoid malignancies.
Nov 24, 2025 | www.globenewswire.com
Adaptive Biotechnologies Corporation $ADPT Stock Position Reduced by Campbell & CO Investment Adviser LLC
Campbell and CO Investment Adviser LLC trimmed its position in Adaptive Biotechnologies Corporation (NASDAQ: ADPT) by 76.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,609 shares of the company's stock after selling 110,331 shares during the quarter. Campbell and CO
Nov 17, 2025 | www.defenseworld.net
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences. Jefferies Global Healthcare Conference in London, UKPresentation on Wednesday, November 19, 2025, at 8:00 a.m.
Nov 06, 2025 | www.globenewswire.com
Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript
Adaptive Biotechnologies Corporation ( ADPT ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Karina Calzadilla - Vice President of Investor Relations Chad Robins - Co-Founder, CEO & Chairman Kyle Piskel - VP, CFO & Principal Accounting Officer Susan Bobulsky - Chief Commercial Officer of MRD Conference Call Participants Mark Massaro - BTIG, LLC, Research Division Subbu Nambi Andrew Brackmann - William Blair & Company L.L.C., Research Division Sebastian Sandler - JPMorgan Chase & Co, Research Division William Bonello David Westenberg - Piper Sandler & Co., Research Division Daniel Brennan Presentation Operator Good day, and thank you for standing by.
Nov 06, 2025 | seekingalpha.com
Adaptive Biotechnologies (ADPT) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Nov 05, 2025 | www.zacks.com
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Beats Revenue Estimates
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.22 per share a year ago.
Nov 05, 2025 | www.zacks.com
Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results
SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended September 30, 2025. “Our third quarter results reflect another period of strong growth and financial progress,” said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies.
Nov 05, 2025 | www.globenewswire.com

Adaptive's Email Address Formats

Adaptive uses at least 1 format(s):

Adaptive Email Formats	Example	Percentage
First@adaptive.live	John@adaptive.live	50%
First@adaptive.live	John@adaptive.live	50%

Frequently Asked Questions

Where is Adaptive's headquarters located?

Adaptive's main headquarters is located at Atlanta, Headquarters US. The company has employees across 3 continents, including AsiaEuropeNorth America.

What is Adaptive's stock symbol?

Adaptive is a publicly traded company; the company's stock symbol is ADPT.

What is Adaptive's official website and social media links?

Adaptive's official website is adaptive.live and has social profiles on LinkedIn Crunchbase.

What is Adaptive's NAICS code?

Adaptive's NAICS code is 5112 - Software Publishers.

How many employees does Adaptive have currently?

As of October 2025, Adaptive has approximately 16 employees across 3 continents, including AsiaEuropeNorth America. Key team members include Co-Founder & Ceo: R. M.Founder & Cto: D. B.Software Engineer: D. S.. Explore Adaptive's employee directory with LeadIQ.

What industry does Adaptive belong to?

Adaptive operates in the Software Development industry.

What technology does Adaptive use?

Adaptive's tech stack includes VarnishCloudflareMySQLjQueryNode.jsLuaHSTSNginx.

What is Adaptive's email format?

Adaptive's email format typically follows the pattern of First@adaptive.live. Find more Adaptive email formats with LeadIQ.

How much funding has Adaptive raised to date?

As of October 2025, Adaptive has raised $2.3M in funding. The last funding round occurred on Sep 30, 2024 for $2.3M.

Adaptive

Q: What is Adaptive's official website and social media links?

Adaptive's official website is adaptive.live. Adaptive has social profiles on LinkedIn.

Q: How many employees does Adaptive have currently?

Adaptive has approximately 16 employees.

Q: What technology does Adaptive use?

Adaptive's tech stack includes Cloudflare Bot Management, Next.js, jQuery Migrate, Vercel, shadcn/ui.

Software DevelopmentAtlanta, United States11-50 Employees

Adaptive is a data security platform that allows organizations to manage and govern access to data sources, monitor database activity, classify and protect sensitive data.

Company Overview

Headquarters: Atlanta, Headquarters US
Website: adaptive.live
Stock Symbol: ADPT
NAICS Code: 5112 - Software Publishers
Employees: 11-50

Media & News

Funding & Financials

$2.3M
Adaptive has raised a total of $2.3M of funding over 2 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $2.3M.
$1M$10M
Adaptive's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$2.3M
Adaptive has raised a total of $2.3M of funding over 2 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $2.3M.
$1M$10M
Adaptive's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Adaptive

Cognizant

TATA Consultancy Services (TCS)

Thoughtworks

Infosys

Accenture

Capgemini

Slalom

Deloitte Digital

EPAM Systems

Globant

Wipro

Adaptive Tech Stack

Media & News

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Adaptive Biotechnologies Corporation $ADPT Stock Position Reduced by Campbell & CO Investment Adviser LLC

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript

Adaptive Biotechnologies (ADPT) Reports Q3 Earnings: What Key Metrics Have to Say

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Beats Revenue Estimates

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

Adaptive's Email Address Formats

Frequently Asked Questions

Where is Adaptive's headquarters located?

What is Adaptive's stock symbol?

What is Adaptive's official website and social media links?

What is Adaptive's NAICS code?

How many employees does Adaptive have currently?

What industry does Adaptive belong to?

What technology does Adaptive use?

What is Adaptive's email format?

How much funding has Adaptive raised to date?

Adaptive

Company Overview

Media & News

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Adaptive Biotechnologies Corporation $ADPT Stock Position Reduced by Campbell & CO Investment Adviser LLC

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?